EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical utility and genetic landscape of exome sequencing in a large pediatric epilepsy cohort: Insights from a Turkish tertiary care center

Derya Karaer iD, Beste Kipçak Yüzbaşı, İpek Şahin, Olcay Güngör, Kadri Karaer iD

Epileptic Disorders · 2026-08 · 28 (4) · 1252-1273

DOI: 10.1002/epd2.70277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epileptic Disorders, online erschienen am 03.07.2026. Verfasst von Derya Karaer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pamukkale University Faculty of Medicine, Department of Medical Genetics, Denizli, Turkiye. Hauptthemen laut MEDLINE: Epilepsy, Exome Sequencing. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the diagnostic utility and genetic spectrum of next‐generation sequencing (NGS) in a large, well‐phenotyped cohort of Turkish pediatric patients with epilepsy of unknown etiology.

Methods

Between January 2021 and December 2024, 250 children (115 female, 135 male) with unexplained epilepsy underwent either whole‐exome sequencing (WES; n = 104) or clinical exome sequencing (CES; n = 146). Variants were interpreted according to the American College of Medical Genetics and Genomics (ACMG) guidelines. Clinical data, including seizure semiology, neuroimaging, EEG findings, and treatment response, were retrospectively reviewed.

Results

A definitive molecular diagnosis (pathogenic or likely pathogenic variants) was established in 89 patients (89/250, 35.6%). Including variants of uncertain significance (VUS) with strong phenotypic correlation raised the diagnostic yield to 57.6% (144/250). The genetic landscape was highly heterogeneous, involving 59 distinct genes. SCN1A was the most frequently implicated gene ( n = 11, 12.4% of diagnosed cases), followed by MECP2 and PRRT2 ( n = 5 each). Notably, the recurrent PRRT2 c.649dup (p.Arg217Profs*8) frameshift variant was identified in four unrelated Turkish families. Inheritance patterns included autosomal dominant (56/89, 63%), autosomal recessive (20/89, 22%), and X‐linked (13/89, 15%). Diagnostic yields were comparable between WES (38/104, 36.5%) and CES (51/146, 35%) ( p = 0.97). Neonatal‐onset epilepsy ( p = 0.03) and the presence of autistic features ( p = 0.04) were significantly associated with a positive genetic diagnosis.

Conclusion

Our study confirms NGS as a first‐tier diagnostic tool in pediatric epilepsy, revealing a distinctive genetic architecture enriched with novel and population‐specific variants. These findings emphasize (1) a high diagnostic yield (∼36%) supporting first‐tier use of NGS; (2) a distinctive genetic architecture characterized by recurrent PRRT2 variants and an elevated burden of autosomal recessive disorders, likely reflecting regional consanguinity patterns; and (3) a phenotype‐driven framework for prioritizing VUS re‐evaluation in clinical neurology practice. Such data from underrepresented populations are crucial for global genomic databases and directly inform precision medicine and genetic counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyExome SequencingHumansMaleTurkeyFemaleChildChild, PreschoolTertiary Care CentersAdolescentInfantRetrospective StudiesNerve Tissue ProteinsCohort StudiesMembrane ProteinsMethyl-CpG-Binding Protein 2NAV1.1 Voltage-Gated Sodium ChannelHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

clinical exome sequencingepilepsygenetic diagnosisgenotype–phenotype correlationnext‐generation sequencingpediatric epilepsywhole‐exome sequencing

Substanzen

PRRT2 protein, humanNerve Tissue ProteinsMembrane ProteinsMethyl-CpG-Binding Protein 2MECP2 protein, humanNAV1.1 Voltage-Gated Sodium ChannelSCN1A protein, human

Autor:innen und Institutionen

  • Pamukkale University Faculty of Medicine, Department of Medical Genetics, Denizli, Turkiye.
  • Pamukkale University, Faculty of Medicine, Department of Pediatric Neurology, Denizli, Turkiye.

ORCID-Profile: Derya Karaer, Kadri Karaer

Zitieren

APA

Karaer, D., Yüzbaşı, B. K., Şahin, İ., Güngör, O., & Karaer, K. (2026). Clinical utility and genetic landscape of exome sequencing in a large pediatric epilepsy cohort: Insights from a Turkish tertiary care center. Epileptic Disorders, 28(4), 1252-1273. https://doi.org/10.1002/epd2.70277

Vancouver

Karaer D, Yüzbaşı BK, Şahin İ, Güngör O, Karaer K. Clinical utility and genetic landscape of exome sequencing in a large pediatric epilepsy cohort: Insights from a Turkish tertiary care center. Epileptic Disorders. 2026;28(4):1252-1273. doi:10.1002/epd2.70277

BibTeX
@article{Karaer2026,
  author = {Karaer, Derya and Yüzbaşı, Beste Kipçak and Şahin, İpek and Güngör, Olcay and Karaer, Kadri},
  title = {Clinical utility and genetic landscape of exome sequencing in a large pediatric epilepsy cohort: Insights from a Turkish tertiary care center},
  journal = {Epileptic Disorders},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {1252--1273},
  doi = {10.1002/epd2.70277}
}
Kostenlos starten →